<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32369233</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-6860</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</Title><ISOAbbreviation>FASEB J</ISOAbbreviation></Journal><ArticleTitle>CHCHD10-regulated OPA1-mitofilin complex mediates TDP-43-induced mitochondrial phenotypes associated with frontotemporal dementia.</ArticleTitle><Pagination><StartPage>8493</StartPage><EndPage>8509</EndPage><MedlinePgn>8493-8509</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1096/fj.201903133RR</ELocationID><Abstract><AbstractText>Mutations in CHCHD10, a gene coding for a mitochondrial protein, are implicated in ALS-FTD spectrum disorders, which are pathologically characterized by transactive response DNA binding protein 43&#xa0;kDa (TDP-43) accumulation. While both TDP-43 and CHCHD10 mutations drive mitochondrial pathogenesis, mechanisms underlying such phenotypes are unclear. Moreover, despite the disruption of the mitochondrial mitofilin protein complex at cristae junctions in patient fibroblasts bearing the CHCHD10<sup>S59L</sup> mutation, the role of CHCHD10 variants in mitofilin-associated protein complexes in brain has not been examined. Here, we utilized novel CHCHD10 transgenic mouse variants (WT, R15L, &amp; S59L), TDP-43 transgenic mice, FTLD-TDP patient brains, and transfected cells to assess the interplay between CHCHD10 and TDP-43 on mitochondrial phenotypes. We show that CHCHD10 mutations disrupt mitochondrial OPA1-mitofilin complexes in brain, associated with impaired mitochondrial fusion and respiration. Likewise, CHCHD10 levels and OPA1-mitofilin complexes are significantly reduced in brains of FTLD-TDP patients and TDP-43 transgenic mice. In cultured cells, CHCHD10 knockdown results in OPA1-mitofilin complex disassembly, while TDP-43 overexpression also reduces CHCHD10, promotes OPA1-mitofilin complex disassembly via CHCHD10, and impairs mitochondrial fusion and respiration, phenotypes that are rescued by wild type (WT) CHCHD10. These results indicate that disruption of CHCHD10-regulated OPA1-mitofilin complex contributes to mitochondrial abnormalities in FTLD-TDP and suggest that CHCHD10 restoration could ameliorate mitochondrial dysfunction in FTLD-TDP.</AbstractText><CopyrightInformation>&#xa9; 2020 Federation of American Societies for Experimental Biology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Byrd Alzheimer's Center &amp; Research Institute, USF Health Morsani College of Medicine, Tampa, FL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular of Medicine, USF Health Morsani College of Medicine, Tampa, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woo</LastName><ForeName>Jung-A A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Byrd Alzheimer's Center &amp; Research Institute, USF Health Morsani College of Medicine, Tampa, FL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Pharmacology and Physiology, USF Health Morsani College of Medicine, Tampa, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bukhari</LastName><ForeName>Mohammed Zaheen</ForeName><Initials>MZ</Initials><AffiliationInfo><Affiliation>Byrd Alzheimer's Center &amp; Research Institute, USF Health Morsani College of Medicine, Tampa, FL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular of Medicine, USF Health Morsani College of Medicine, Tampa, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>LePochat</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Byrd Alzheimer's Center &amp; Research Institute, USF Health Morsani College of Medicine, Tampa, FL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular of Medicine, USF Health Morsani College of Medicine, Tampa, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chacko</LastName><ForeName>Ann</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Byrd Alzheimer's Center &amp; Research Institute, USF Health Morsani College of Medicine, Tampa, FL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular of Medicine, USF Health Morsani College of Medicine, Tampa, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selenica</LastName><ForeName>Maj-Linda B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Byrd Alzheimer's Center &amp; Research Institute, USF Health Morsani College of Medicine, Tampa, FL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular of Medicine, USF Health Morsani College of Medicine, Tampa, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotsiviras</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Byrd Alzheimer's Center &amp; Research Institute, USF Health Morsani College of Medicine, Tampa, FL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular of Medicine, USF Health Morsani College of Medicine, Tampa, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buosi</LastName><ForeName>Sara Cazzaro</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Byrd Alzheimer's Center &amp; Research Institute, USF Health Morsani College of Medicine, Tampa, FL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular of Medicine, USF Health Morsani College of Medicine, Tampa, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Xingyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Byrd Alzheimer's Center &amp; Research Institute, USF Health Morsani College of Medicine, Tampa, FL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular of Medicine, USF Health Morsani College of Medicine, Tampa, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>David E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Byrd Alzheimer's Center &amp; Research Institute, USF Health Morsani College of Medicine, Tampa, FL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular of Medicine, USF Health Morsani College of Medicine, Tampa, FL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>James A. Haley Veterans Administration Hospital, Tampa, FL, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>I01 BX002478</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG053060</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS073899</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>FASEB J</MedlineTA><NlmUniqueID>8804484</NlmUniqueID><ISSNLinking>0892-6638</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C554426">CHCHD10 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C088548">IMMT protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024101">Mitochondrial Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009124">Muscle Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="D020558">GTP Phosphohydrolases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C415198">OPA1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020558" MajorTopicYN="N">GTP Phosphohydrolases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063154" MajorTopicYN="N">Mitochondrial Dynamics</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051336" MajorTopicYN="N">Mitochondrial Membranes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024101" MajorTopicYN="N">Mitochondrial Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009124" MajorTopicYN="N">Muscle Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D041681" MajorTopicYN="N">NIH 3T3 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CHCHD10</Keyword><Keyword MajorTopicYN="N">OPA1</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">mitofilin</Keyword></KeywordList><CoiStatement>Conflict of interest. The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32369233</ArticleId><ArticleId IdType="mid">NIHMS1597624</ArticleId><ArticleId IdType="pmc">PMC7482311</ArticleId><ArticleId IdType="doi">10.1096/fj.201903133RR</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lomen-Hoerth C, Anderson T, and Miller B (2002) The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 59, 1077&#x2013;1079</Citation><ArticleIdList><ArticleId IdType="pubmed">12370467</ArticleId></ArticleIdList></Reference><Reference><Citation>Feneberg E, Gray E, Ansorge O, Talbot K, and Turner MR (2018) Towards a TDP-43-Based Biomarker for ALS and FTLD. Mol Neurobiol 55, 7789&#x2013;7801</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6132775</ArticleId><ArticleId IdType="pubmed">29460270</ArticleId></ArticleIdList></Reference><Reference><Citation>Muyderman H, and Chen T (2014) Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target? Br J Pharmacol 171, 2191&#x2013;2205</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3976630</ArticleId><ArticleId IdType="pubmed">24148000</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EF, Shaw PJ, and De Vos KJ (2017) The role of mitochondria in amyotrophic lateral sclerosis. Neurosci Lett</Citation></Reference><Reference><Citation>Borthwick GM, Johnson MA, Ince PG, Shaw PJ, and Turnbull DM (1999) Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death. Ann Neurol 46, 787&#x2013;790</Citation><ArticleIdList><ArticleId IdType="pubmed">10553999</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P, Deng J, Dong J, Liu J, Bigio EH, Mesulam M, Wang T, Sun L, Wang L, Lee AY, McGee WA, Chen X, Fushimi K, Zhu L, and Wu JY (2019) TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response. PLoS Genet 15, e1007947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6524796</ArticleId><ArticleId IdType="pubmed">31100073</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu YF, Gendron TF, Zhang YJ, Lin WL, D'Alton S, Sheng H, Casey MC, Tong J, Knight J, Yu X, Rademakers R, Boylan K, Hutton M, McGowan E, Dickson DW, Lewis J, and Petrucelli L (2010) Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J Neurosci 30, 10851&#x2013;10859</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3056148</ArticleId><ArticleId IdType="pubmed">20702714</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo JA, Liu T, Trotter C, Fang CC, De Narvaez E, LePochat P, Maslar D, Bukhari A, Zhao X, Deonarine A, Westerheide SD, and Kang DE (2017) Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity. Nat Commun 8, 15558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5467170</ArticleId><ArticleId IdType="pubmed">28585542</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang TC, Handley E, Brizuela M, Dawkins E, Lewis KEA, Clark RM, Dickson TC, and Blizzard CA (2019) Amyotrophic lateral sclerosis mutant TDP-43 may cause synaptic dysfunction through altered dendritic spine function. Dis Model Mech 12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6550035</ArticleId><ArticleId IdType="pubmed">31036551</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Wang L, Lu J, Siedlak SL, Fujioka H, Liang J, Jiang S, Ma X, Jiang Z, da Rocha EL, Sheng M, Choi H, Lerou PH, Li H, and Wang X (2016) The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat Med 22, 869&#x2013;878</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4974139</ArticleId><ArticleId IdType="pubmed">27348499</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Li L, Lin WL, Dickson DW, Petrucelli L, Zhang T, and Wang X (2013) The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum Mol Genet 22, 4706&#x2013;4719</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3820133</ArticleId><ArticleId IdType="pubmed">23827948</ArticleId></ArticleIdList></Reference><Reference><Citation>Rampelt H, Zerbes RM, van der Laan M, and Pfanner N (2017) Role of the mitochondrial contact site and cristae organizing system in membrane architecture and dynamics. Bba-Mol Cell Res 1864, 737&#x2013;746</Citation><ArticleIdList><ArticleId IdType="pubmed">27614134</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Ruan Y, Zhang K, Jian F, Hu C, Miao L, Gong L, Sun L, Zhang X, Chen S, Chen H, Liu D, and Song Z (2016) Mic60/Mitofilin determines MICOS assembly essential for mitochondrial dynamics and mtDNA nucleoid organization. Cell Death Differ 23, 380&#x2013;392</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5072434</ArticleId><ArticleId IdType="pubmed">26250910</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaurov I, Vancova M, Schimanski B, Cadena LR, Heller J, Bily T, Potesil D, Eichenberger C, Bruce H, Oeljeklaus S, Warscheid B, Zdrahal Z, Schneider A, Lukes J, and Hashimi H (2018) The Diverged Trypanosome MICOS Complex as a Hub for Mitochondrial Cristae Shaping and Protein Import. Curr Biol 28, 3393-+</Citation><ArticleIdList><ArticleId IdType="pubmed">30415698</ArticleId></ArticleIdList></Reference><Reference><Citation>Callegari S, Muller T, Schulz C, Lenz C, Jans DC, Wissel M, Opazo F, Rizzoli SO, Jakobs S, Urlaub H, Rehling P, and Deckers M (2019) A MICOS-TIM22 Association Promotes Carrier Import into Human Mitochondria. J Mol Biol</Citation><ArticleIdList><ArticleId IdType="pubmed">31103774</ArticleId></ArticleIdList></Reference><Reference><Citation>Harner M, Korner C, Walther D, Mokranjac D, Kaesmacher J, Welsch U, Griffith J, Mann M, Reggiori F, and Neupert W (2011) The mitochondrial contact site complex, a determinant of mitochondrial architecture. EMBO J 30, 4356&#x2013;4370</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3230385</ArticleId><ArticleId IdType="pubmed">22009199</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman JR, Mourier A, Yamada J, McCaffery JM, and Nunnari J (2015) MICOS coordinates with respiratory complexes and lipids to establish mitochondrial inner membrane architecture. Elife 4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4434539</ArticleId><ArticleId IdType="pubmed">25918844</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho B, Cho HM, Jo Y, Kim HD, Song M, Moon C, Kim H, Kim K, Sesaki H, Rhyu IJ, Kim H, and Sun W (2017) Constriction of the mitochondrial inner compartment is a priming event for mitochondrial division. Nat Commun 8, 15754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5472732</ArticleId><ArticleId IdType="pubmed">28598422</ArticleId></ArticleIdList></Reference><Reference><Citation>Malka F, Guillery O, Cifuentes-Diaz C, Guillou E, Belenguer P, Lombes A, and Rojo M (2005) Separate fusion of outer and inner mitochondrial membranes. EMBO Rep 6, 853&#x2013;859</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1369163</ArticleId><ArticleId IdType="pubmed">16113651</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Z, Ghochani M, McCaffery JM, Frey TG, and Chan DC (2009) Mitofusins and OPA1 mediate sequential steps in mitochondrial membrane fusion. Mol Biol Cell 20, 3525&#x2013;3532</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2719570</ArticleId><ArticleId IdType="pubmed">19477917</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Dotto V, Mishra P, Vidoni S, Fogazza M, Maresca A, Caporali L, McCaffery JM, Cappelletti M, Baruffini E, Lenaers G, Chan D, Rugolo M, Carelli V, and Zanna C (2017) OPA1 Isoforms in the Hierarchical Organization of Mitochondrial Functions. Cell reports 19, 2557&#x2013;2571</Citation><ArticleIdList><ArticleId IdType="pubmed">28636943</ArticleId></ArticleIdList></Reference><Reference><Citation>Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko GV, Rudka T, Bartoli D, Polishuck RS, Danial NN, De Strooper B, and Scorrano L (2006) OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 126, 177&#x2013;189</Citation><ArticleIdList><ArticleId IdType="pubmed">16839885</ArticleId></ArticleIdList></Reference><Reference><Citation>Glytsou C, Calvo E, Cogliati S, Mehrotra A, Anastasia I, Rigoni G, Raimondi A, Shintani N, Loureiro M, Vazquez J, Pellegrini L, Enriquez JA, Scorrano L, and Soriano ME (2016) Optic Atrophy 1 Is Epistatic to the Core MICOS Component MIC60 in Mitochondrial Cristae Shape Control. Cell Rep 17, 3024&#x2013;3034</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5186903</ArticleId><ArticleId IdType="pubmed">27974214</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannwarth S, Ait-El-Mkadem S, Chaussenot A, Genin EC, Lacas-Gervais S, Fragaki K, Berg-Alonso L, Kageyama Y, Serre V, Moore DG, Verschueren A, Rouzier C, Le Ber I, Auge G, Cochaud C, Lespinasse F, N'Guyen K, de Septenville A, Brice A, Yu-Wai-Man P, Sesaki H, Pouget J, and Paquis-Flucklinger V (2014) A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain 137, 2329&#x2013;2345</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4107737</ArticleId><ArticleId IdType="pubmed">24934289</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JO, Glynn SM, Gibbs JR, Nalls MA, Sabatelli M, Restagno G, Drory VE, Chio A, Rogaeva E, and Traynor BJ (2014) Mutations in the CHCHD10 gene are a common cause of familial amyotrophic lateral sclerosis. Brain 137, e311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4240285</ArticleId><ArticleId IdType="pubmed">25261972</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller K, Andersen PM, Hubers A, Marroquin N, Volk AE, Danzer KM, Meitinger T, Ludolph AC, Strom TM, and Weishaupt JH (2014) Two novel mutations in conserved codons indicate that CHCHD10 is a gene associated with motor neuron disease. Brain 137, e309.</Citation><ArticleIdList><ArticleId IdType="pubmed">25113787</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Xi Z, Zinman L, Bruni AC, Maletta RG, Curcio SA, Rainero I, Rubino E, Pinessi L, Nacmias B, Sorbi S, Galimberti D, Lang AE, Fox S, Surace EI, Ghani M, Guo J, Sato C, Moreno D, Liang Y, Keith J, Traynor BJ, St George-Hyslop P, and Rogaeva E (2015) Mutation analysis of CHCHD10 in different neurodegenerative diseases. Brain 138, e380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4547051</ArticleId><ArticleId IdType="pubmed">25833818</ArticleId></ArticleIdList></Reference><Reference><Citation>Penttila S, Jokela M, Bouquin H, Saukkonen AM, Toivanen J, and Udd B (2015) Late onset spinal motor neuronopathy is caused by mutation in CHCHD10. Ann Neurol 77, 163&#x2013;172</Citation><ArticleIdList><ArticleId IdType="pubmed">25428574</ArticleId></ArticleIdList></Reference><Reference><Citation>Auranen M, Ylikallio E, Shcherbii M, Paetau A, Kiuru-Enari S, Toppila JP, and Tyynismaa H (2015) CHCHD10 variant p.(Gly66Val) causes axonal Charcot-Marie-Tooth disease. Neurology. Genetics 1, e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4821082</ArticleId><ArticleId IdType="pubmed">27066538</ArticleId></ArticleIdList></Reference><Reference><Citation>Burstein SR, Valsecchi F, Kawamata H, Bourens M, Zeng R, Zuberi A, Milner TA, Cloonan SM, Lutz C, Barrientos A, and Manfredi G (2018) In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions. Human molecular genetics 27, 160&#x2013;177</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5886281</ArticleId><ArticleId IdType="pubmed">29112723</ArticleId></ArticleIdList></Reference><Reference><Citation>Genin EC, Plutino M, Bannwarth S, Villa E, Cisneros-Barroso E, Roy M, Ortega-Vila B, Fragaki K, Lespinasse F, Pinero-Martos E, Auge G, Moore D, Burte F, Lacas-Gervais S, Kageyama Y, Itoh K, Yu-Wai-Man P, Sesaki H, Ricci JE, Vives-Bauza C, and Paquis-Flucklinger V (2016) CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis. Embo Mol Med 8, 58&#x2013;72</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4718158</ArticleId><ArticleId IdType="pubmed">26666268</ArticleId></ArticleIdList></Reference><Reference><Citation>Genin EC, Bannwarth S, Lespinasse F, Ortega-Vila B, Fragaki K, Itoh K, Villa E, Lacas-Gervais S, Jokela M, Auranen M, Ylikallio E, Mauri-Crouzet A, Tyynismaa H, Vihola A, Auge G, Cochaud C, Sesaki H, Ricci JE, Udd B, Vives-Bauza C, and Paquis-Flucklinger V (2018) Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases. Neurobiol Dis 119, 159&#x2013;171</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7015038</ArticleId><ArticleId IdType="pubmed">30092269</ArticleId></ArticleIdList></Reference><Reference><Citation>Wils H, Kleinberger G, Janssens J, Pereson S, Joris G, Cuijt I, Smits V, Ceuterick-de Groote C, Van Broeckhoven C, and Kumar-Singh S (2010) TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A 107, 3858&#x2013;3863</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2840518</ArticleId><ArticleId IdType="pubmed">20133711</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, Copeland NG, Lee MK, Younkin LH, Wagner SL, Younkin SG, and Borchelt DR (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Human molecular genetics 13, 159&#x2013;170</Citation><ArticleIdList><ArticleId IdType="pubmed">14645205</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido TC, Maeda J, Suhara T, Trojanowski JQ, and Lee VM (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337&#x2013;351</Citation><ArticleIdList><ArticleId IdType="pubmed">17270732</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MK, Stirling W, Xu Y, Xu X, Qui D, Mandir AS, Dawson TM, Copeland NG, Jenkins NA, and Price DL (2002) Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --&gt; Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 99, 8968&#x2013;8973</Citation><ArticleIdList><ArticleId IdType="pmc">PMC124407</ArticleId><ArticleId IdType="pubmed">12084935</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo JA, Liu T, Fang CC, Cazzaro S, Kee T, LePochat P, Yrigoin K, Penn C, Zhao X, Wang X, Liggett SB, and Kang DE (2019) Activated cofilin exacerbates tau pathology by impairing tau-mediated microtubule dynamics. Commun Biol 2, 112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6430779</ArticleId><ArticleId IdType="pubmed">30911686</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham AH, McCaffery JM, and Chan DC (2012) Mouse lines with photo-activatable mitochondria to study mitochondrial dynamics. Genesis 50, 833&#x2013;843</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3508687</ArticleId><ArticleId IdType="pubmed">22821887</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo JA, Liu T, Zhao X, Trotter C, Yrigoin K, Cazzaro S, Narvaez E, Khan H, Witas R, Bukhari A, Makati K, Wang X, Dickey C, and Kang DE (2017) Enhanced tau pathology via RanBP9 and Hsp90/Hsc70 chaperone complexes. Human molecular genetics 26, 3973&#x2013;3988</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6075219</ArticleId><ArticleId IdType="pubmed">29016855</ArticleId></ArticleIdList></Reference><Reference><Citation>Fredriksson S, Gullberg M, Jarvius J, Olsson C, Pietras K, Gustafsdottir SM, Ostman A, and Landegren U (2002) Protein detection using proximity-dependent DNA ligation assays. Nat Biotechnol 20, 473&#x2013;477</Citation><ArticleIdList><ArticleId IdType="pubmed">11981560</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson CJ, Bredvik K, Burstein SR, Davis C, Meadows SM, Dash J, Case L, Milner TA, Kawamata H, Zuberi A, Piersigilli A, Lutz C, and Manfredi G (2019) ALS/FTD mutant CHCHD10 mice reveal a tissue-specific toxic gain-of-function and mitochondrial stress response. Acta Neuropathol</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6571048</ArticleId><ArticleId IdType="pubmed">30877432</ArticleId></ArticleIdList></Reference><Reference><Citation>Genin EC, Madji Hounoum B, Bannwarth S, Fragaki K, Lacas-Gervais S, Mauri-Crouzet A, Lespinasse F, Neveu J, Ropert B, Auge G, Cochaud C, Lefebvre-Omar C, Bigou S, Chiot A, Mochel F, Boillee S, Lobsiger CS, Bohl D, Ricci JE, and Paquis-Flucklinger V (2019) Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10(S59L/+) mouse. Acta Neuropathol</Citation><ArticleIdList><ArticleId IdType="pubmed">30874923</ArticleId></ArticleIdList></Reference><Reference><Citation>Brockmann SJ, Freischmidt A, Oeckl P, Muller K, Ponna SK, Helferich AM, Paone C, Reinders J, Kojer K, Orth M, Jokela M, Auranen M, Udd B, Hermann A, Danzer KM, Lichtner P, Walther P, Ludolph AC, Andersen PM, Otto M, Kursula P, Just S, and Weishaupt JH (2018) CHCHD10 mutations p.R15L and p.G66V cause motoneuron disease by haploinsufficiency. Human molecular genetics 27, 706&#x2013;715</Citation><ArticleIdList><ArticleId IdType="pubmed">29315381</ArticleId></ArticleIdList></Reference><Reference><Citation>Straub IR, Janer A, Weraarpachai W, Zinman L, Robertson J, Rogaeva E, and Shoubridge EA (2018) Loss of CHCHD10-CHCHD2 complexes required for respiration underlies the pathogenicity of a CHCHD10 mutation in ALS. Human molecular genetics 27, 178&#x2013;189</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5886208</ArticleId><ArticleId IdType="pubmed">29121267</ArticleId></ArticleIdList></Reference><Reference><Citation>Su C, Wang F, Ciolek D, and Pan YC (1994) Electrophoresis of proteins and protein-protein complexes in native polyacrylamide gels using a horizontal gel apparatus. Anal Biochem 223, 93&#x2013;98</Citation><ArticleIdList><ArticleId IdType="pubmed">7695108</ArticleId></ArticleIdList></Reference><Reference><Citation>MacVicar T, and Langer T (2016) OPA1 processing in cell death and disease - the long and short of it. J Cell Sci 129, 2297&#x2013;2306</Citation><ArticleIdList><ArticleId IdType="pubmed">27189080</ArticleId></ArticleIdList></Reference><Reference><Citation>Wai T, Garcia-Prieto J, Baker MJ, Merkwirth C, Benit P, Rustin P, Ruperez FJ, Barbas C, Ibanez B, and Langer T (2015) Imbalanced OPA1 processing and mitochondrial fragmentation cause heart failure in mice. Science 350, aad0116.</Citation><ArticleIdList><ArticleId IdType="pubmed">26785494</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Li L, and Jiang H (2017) Mitochondrial inner-membrane protease Yme1 degrades outer-membrane proteins Tom22 and Om45. J Cell Biol</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5748973</ArticleId><ArticleId IdType="pubmed">29138251</ArticleId></ArticleIdList></Reference><Reference><Citation>Delettre C, Griffoin JM, Kaplan J, Dollfus H, Lorenz B, Faivre L, Lenaers G, Belenguer P, and Hamel CP (2001) Mutation spectrum and splicing variants in the OPA1 gene. Hum Genet 109, 584&#x2013;591</Citation><ArticleIdList><ArticleId IdType="pubmed">11810270</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X, Wu BP, Nguyen D, Liu YT, Marani M, Hench J, Benit P, Kozjak-Pavlovic V, Rustin P, Frank S, and Narendra DP (2019) CHCHD2 accumulates in distressed mitochondria and facilitates oligomerization of CHCHD10. Human molecular genetics 28, 349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6322067</ArticleId><ArticleId IdType="pubmed">30285108</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng H, Yamashita C, Shiba-Fukushima K, Inoshita T, Funayama M, Sato S, Hatta T, Natsume T, Umitsu M, Takagi J, Imai Y, and Hattori N (2017) Loss of Parkinson's disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c. Nat Commun 8, 15500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5467237</ArticleId><ArticleId IdType="pubmed">28589937</ArticleId></ArticleIdList></Reference><Reference><Citation>Purandare N, Somayajulu M, Huttemann M, Grossman LI, and Aras S (2018) The cellular stress proteins CHCHD10 and MNRR1 (CHCHD2): Partners in mitochondrial and nuclear function and dysfunction. J Biol Chem 293, 6517&#x2013;6529</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5925800</ArticleId><ArticleId IdType="pubmed">29540477</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Duan XY, Xu LN, Shang WN, Zhao JY, Wang LQ, Li JC, Chen CH, Liu JP, and Tong C (2020) Chchd2 regulates mitochondrial morphology by modulating the levels of Opa1. Cell Death Differ</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7244760</ArticleId><ArticleId IdType="pubmed">31907391</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynen MA, Muhlmeister M, Gotthardt K, Guerrero-Castillo S, and Brandt U (2016) Evolution and structural organization of the mitochondrial contact site (MICOS) complex and the mitochondrial intermembrane space bridging (MIB) complex. Biochim Biophys Acta 1863, 91&#x2013;101</Citation><ArticleIdList><ArticleId IdType="pubmed">26477565</ArticleId></ArticleIdList></Reference><Reference><Citation>Darshi M, Mendiola VL, Mackey MR, Murphy AN, Koller A, Perkins GA, Ellisman MH, and Taylor SS (2011) ChChd3, an inner mitochondrial membrane protein, is essential for maintaining crista integrity and mitochondrial function. J Biol Chem 286, 2918&#x2013;2932</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3024787</ArticleId><ArticleId IdType="pubmed">21081504</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarani V, McNeill EM, Paulo JA, Huttlin EL, Frohlich F, Gygi SP, Van Vactor D, and Harper JW (2015) QIL1 is a novel mitochondrial protein required for MICOS complex stability and cristae morphology. Elife 4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4439739</ArticleId><ArticleId IdType="pubmed">25997101</ArticleId></ArticleIdList></Reference><Reference><Citation>Aras S, Pak O, Sommer N, Finley R Jr., Huttemann M, Weissmann N, and Grossman LI (2013) Oxygen-dependent expression of cytochrome c oxidase subunit 4-2 gene expression is mediated by transcription factors RBPJ, CXXC5 and CHCHD2. Nucleic Acids Res 41, 2255&#x2013;2266</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3575822</ArticleId><ArticleId IdType="pubmed">23303788</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Yokoshi M, Okada H, and Kawahara Y (2015) The cleavage pattern of TDP-43 determines its rate of clearance and cytotoxicity. Nat Commun 6, 6183.</Citation><ArticleIdList><ArticleId IdType="pubmed">25630387</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoica R, De Vos KJ, Paillusson S, Mueller S, Sancho RM, Lau KF, Vizcay-Barrena G, Lin WL, Xu YF, Lewis J, Dickson DW, Petrucelli L, Mitchell JC, Shaw CE, and Miller CC (2014) ER-mitochondria associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43. Nat Commun 5, 3996.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4046113</ArticleId><ArticleId IdType="pubmed">24893131</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C, Zennaro E, Fallini C, Weber M, Sommacal A, Buratti E, Silani V, and Ratti A (2009) TDP-43 is recruited to stress granules in conditions of oxidative insult. J Neurochem 111, 1051&#x2013;1061</Citation><ArticleIdList><ArticleId IdType="pubmed">19765185</ArticleId></ArticleIdList></Reference><Reference><Citation>Alami NH, Smith RB, Carrasco MA, Williams LA, Winborn CS, Han SSW, Kiskinis E, Winborn B, Freibaum BD, Kanagaraj A, Clare AJ, Badders NM, Bilican B, Chaum E, Chandran S, Shaw CE, Eggan KC, Maniatis T, and Taylor JP (2014) Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron 81, 536&#x2013;543</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3939050</ArticleId><ArticleId IdType="pubmed">24507191</ArticleId></ArticleIdList></Reference><Reference><Citation>Youle RJ, and van der Bliek AM (2012) Mitochondrial fission, fusion, and stress. Science 337, 1062&#x2013;1065</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4762028</ArticleId><ArticleId IdType="pubmed">22936770</ArticleId></ArticleIdList></Reference><Reference><Citation>Amati-Bonneau P, Valentino ML, Reynier P, Gallardo ME, Bornstein B, Boissiere A, Campos Y, Rivera H, de la Aleja JG, Carroccia R, Iommarini L, Labauge P, Figarella-Branger D, Marcorelles P, Furby A, Beauvais K, Letournel F, Liguori R, La Morgia C, Montagna P, Liguori M, Zanna C, Rugolo M, Cossarizza A, Wissinger B, Verny C, Schwarzenbacher R, Martin MA, Arenas J, Ayuso C, Garesse R, Lenaers G, Bonneau D, and Carelli V (2008) OPA1 mutations induce mitochondrial DNA instability and optic atrophy &#x2018;plus&#x2019; phenotypes. Brain 131, 338&#x2013;351</Citation><ArticleIdList><ArticleId IdType="pubmed">18158317</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi AU, Saw NL, Vogel H, Cunnigham AD, Shamloo M, and Mochly-Rosen D (2018) Inhibition of Drp1/Fis1 interaction slows progression of amyotrophic lateral sclerosis. Embo Mol Med 10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5840540</ArticleId><ArticleId IdType="pubmed">29335339</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis SA, Itaman S, Khalid-Janney CM, Sherard JA, Dowell JA, Cairns NJ, and Gitcho MA (2018) TDP-43 interacts with mitochondrial proteins critical for mitophagy and mitochondrial dynamics. Neurosci Lett 678, 8&#x2013;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5975202</ArticleId><ArticleId IdType="pubmed">29715546</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Duan W, Guo Y, Jiang H, Li Z, Huang J, Hong K, and Li C (2012) Mitochondrial dysfunction in human TDP-43 transfected NSC34 cell lines and the protective effect of dimethoxy curcumin. Brain Res Bull 89, 185&#x2013;190</Citation><ArticleIdList><ArticleId IdType="pubmed">22986236</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>